NEW YORK (GenomeWeb News) – MDxHealth today said that it has raised €18 million ($23.6 million) through a private placement of new shares.

The Liege, Belgium-based molecular diagnostics developer said that it issued 8,737,683 shares at a price of €2.06 per share, the average closing price of the firm's shares on the NYSE Euronext market during the 30 preceding calendar days.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.